Skip to content

Company information lookup


Conduct clinical trials, research and commercialisation of a number of anti-viral (HCV and HIV) drugs developed from biomedical projects researched at the John Curtin School of Medical Research.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BIT 0.100 -4.76% 0.098 0.100 0.100 0.100 0.098 408,928


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BIT
Official Listing Date 24 January, 2001
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address Level 2, 66 Hunter Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9300 3344
Head Office Fax (02) 9221 6333
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Michael J Hoy (Non Exec. Chairman, Independent Director)
Dr Michelle Miller (Managing Director)
Dr Susan M Pond (Non Exec. Director, Independent Director)
Mr Robert B Thomas (Non Exec. Director, Independent Director)
Dr Denis N Wade (Non Exec. Director, Independent Director)
Company Secretary Mr Peter J Nightingale
Principal Activities Conduct clinical trials, research and commercialisation of a number of anti-viral (HCV and HIV) drugs developed from biomedical projects researched at the John Curtin School of Medical Research.

BIOTRON LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
19/12/2014   Appendix 3B 9 PDF
10/12/2014   Details of Share Registry Address 1 PDF
04/12/2014   Presentation to Investors 17 PDF
03/12/2014 asterix Enrolment of Phase 2 Hepatitis C Trial of BIT225 Completed 2 PDF
03/12/2014   Appendix 3B 9 PDF
20/11/2014   Change of Director's Interest Notice 3 PDF
13/11/2014   Results of Meeting 2 PDF
13/11/2014   Chairman's Address to Shareholders 22 PDF
12/11/2014   Change of Director's Interest Notice 10 PDF
05/11/2014   Fully Underwritten Rights Issue Closes Oversubscribed 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Dec 2014 0.100 -4.76% 0.100 0.098 408,928
18 Dec 2014 0.105 5% 0.105 0.097 617,960
17 Dec 2014 0.100 0% 0.100 0.100 75,000
16 Dec 2014 0.100 -4.76% 0.105 0.099 346,350
15 Dec 2014 0.105 -4.55% 0.110 0.100 369,108

* Volume of shares shown represents only those shares traded on ASX.

BIOTRON LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security BIT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BIT

Warrants & Structured Products

No warrants & Structured Products are available over the security BIT